Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Unusual patterns of endometrial carcinoma including MELF and its relation to epithelial mesenchymal transition.

Zaino RJ.

Int J Gynecol Pathol. 2014 Jul;33(4):357-64. doi: 10.1097/PGP.0000000000000137. Review.

PMID:
24901395
3.
4.

Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial-mesenchymal transition.

Stewart CJ, Little L.

Histopathology. 2009 Jul;55(1):91-101. doi: 10.1111/j.1365-2559.2009.03327.x.

PMID:
19614771
5.
6.

Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.

Demopoulos RI, Mesia AF, Mittal K, Vamvakas E.

Int J Gynecol Pathol. 1999 Jul;18(3):233-7.

PMID:
12092593
7.

Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.

Kihara A, Yoshida H, Watanabe R, Takahashi K, Kato T, Ino Y, Kitagawa M, Hiraoka N.

Am J Surg Pathol. 2017 Jul;41(7):896-905. doi: 10.1097/PAS.0000000000000856.

PMID:
28418994
8.

Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.

Montserrat N, Mozos A, Llobet D, Dolcet X, Pons C, de Herreros AG, Matias-Guiu X, Prat J.

Hum Pathol. 2012 May;43(5):632-43. doi: 10.1016/j.humpath.2011.06.021. Epub 2011 Sep 21.

PMID:
21940036
9.

The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.

Nishimura S, Ito YM, Tsuda H, Ohnishi Y, Kataoka F, Nomura H, Chiyoda T, Suzuki A, Susumu N, Aoki D, Hatae M.

Eur J Obstet Gynecol Reprod Biol. 2010 Jan;148(1):67-72. doi: 10.1016/j.ejogrb.2009.09.016.

PMID:
19815329
10.

Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium.

Stewart CJ, Crook ML, Lacey J, Louwen K.

Int J Gynecol Pathol. 2011 Sep;30(5):484-91. doi: 10.1097/PGP.0b013e3182158944.

PMID:
21804393
12.

The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.

Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z.

Am J Surg Pathol. 2008 Feb;32(2):304-15. doi: 10.1097/PAS.0b013e3181483ff8.

PMID:
18223334
13.

Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.

Truskinovsky AM, Lifschitz-Mercer B, Czernobilsky B.

Int J Gynecol Pathol. 2014 Mar;33(2):107-13. doi: 10.1097/PGP.0b013e3182a2945d.

PMID:
24487463
14.

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.

Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ.

Hum Pathol. 1995 Nov;26(11):1260-7.

PMID:
7590702
15.

Micro-anatomical variation in cellular proliferation in endometrial adenocarcinoma, and inverse correlation between Ki67 and cytokeratin 7 expression.

Stewart CJ, Crook ML, Doherty DA.

Histopathology. 2010 Jul;57(1):46-54. doi: 10.1111/j.1365-2559.2010.03588.x. Epub 2010 Jun 14.

PMID:
20557372
16.

Endometrioid carcinoma of the endometrium: pathologic and molecular features.

Azueta A, Gatius S, Matias-Guiu X.

Semin Diagn Pathol. 2010 Nov;27(4):226-40. Review.

PMID:
21309258
18.

Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands.

Stewart CJ, Crook ML, Leung YC, Platten M.

Mod Pathol. 2009 May;22(5):725-33. doi: 10.1038/modpathol.2009.33. Epub 2009 Mar 6.

19.
20.

Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.

Shaco-Levy R, Sharabi S, Benharroch D, Piura B, Sion-Vardy N.

Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):226-32. doi: 10.1016/j.ejogrb.2008.01.004. Epub 2008 Mar 4.

PMID:
18295959

Supplemental Content

Support Center